ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

PPIR Prophotonix S

9.50
0.00 (0.00%)
21 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Prophotonix S LSE:PPIR London Ordinary Share COM SHS USD0.001 (REG S / DI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 9.50 6.00 13.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

ProPhotonix Limited ProPhotonix annouces results -2-

19/03/2015 7:01am

UK Regulatory


ProPhotonix Limited, headquartered in Salem, New Hampshire, is an independent designer and manufacturer of diode-based laser modules and LED systems for industry leading OEMs and medical equipment companies. In addition, the Company distributes premium diodes for Ushio (formerly Opnext), Osram, QSI, Panasonic, and Sony. The Company serves a wide range of markets including the machine vision, industrial inspection, security, and medical markets. ProPhotonix has offices and subsidiaries in the U.S., Ireland, U.K., and Europe. For more information about ProPhotonix and its innovative products, visit the Company's web site at www.prophotonix.com.

 
                                     ProPhotonix Limited 
                Consolidated Statements of Operations and Comprehensive (Loss) 
                       ($ in thousands except share and per share data) 
                                         (unaudited) 
                                                                     Years Ended 
                                                                     December 31, 
                                                               2014               2013 
                                                        ------------------  ----------------- 
Net Revenue                                                       $ 16,431           $ 15,599 
Cost of Revenue                                                   (10,006)            (9,628) 
                                                        ------------------  ----------------- 
Gross Profit                                                         6,425              5,971 
                                                        ------------------  ----------------- 
Research & Development Expenses                                      (879)              (941) 
Selling, General & Administrative Expenses                         (5,350)            (6,091) 
Amortization of Intangible Assets                                    (100)              (120) 
                                                        ------------------  ----------------- 
Operating Income (Loss)                                                 96            (1,181) 
                                                        ------------------  ----------------- 
Other Income / (Expense), net                                           93                117 
Foreign Currency translation gains (losses)                        (1,031)                178 
Warrant and Debt Acquisition expense                                 (198)              (103) 
Interest Expense                                                     (300)              (237) 
                                                        ------------------  ----------------- 
Loss Before Taxes                                                  (1,340)            (1,226) 
Tax Benefit                                                              -                 73 
                                                        ------------------  ----------------- 
Net Loss                                                        $ ( 1,340)         $ ( 1,153) 
Other comprehensive income / (loss): 
    Foreign currency translation                                       958              (368) 
                                                        ------------------ 
Total comprehensive loss                                          $ ( 382)         $ ( 1,521) 
                                                        ==================  ================= 
Loss Per Share: 
Basic and diluted net loss per share                               ($0.02)            ($0.01) 
Basic and diluted weighted average shares outstanding           83,665,402         80,496,977 
------------------------------------------------------  ------------------  ----------------- 
 

PROPHOTONIX LIMITED

CONSOLIDATED BALANCE SHEETS

 
 
                     (unaudited) 
   ($ in thousands except share and per share data) 
 
 
 
                       December 31                                          2014                         2013 
 
Assets 
Current assets: 
Cash and cash equivalents                                                         $ 331                        $ 402 
Accounts receivable, less allowances of $20 in 2014 and 
 $19 in 2013                                                                      2,606                        2,559 
Inventories                                                                       1,686                        2,003 
Prepaid expenses and other current assets                                           180                          220 
 
        Total current assets                                                      4,803                        5,184 
Net property, plant and equipment                                                   184                          303 
Goodwill                                                                            429                          486 
Acquired intangible assets, net                                                       -                          102 
Other long-term assets                                                              206                          354 
 
        Total assets                                                            $ 5,622                      $ 6,429 
 
Liabilities and Stockholders' (Deficit) 
Current liabilities: 
Revolving credit facility                                                       $ 1,140                      $ 1,127 
Current portion of long-term debt                                                   770                          265 
Capital lease obligations                                                             -                           10 
Accounts payable                                                                  1,463                        1,542 
Accrued expenses                                                                    965                        1,296 
 
        Total current liabilities                                                 4,338                        4,240 
Long-term debt, net of current portion                                            1,641                        2,445 
Other long-term liabilities                                                         178                          178 
 
        Total liabilities                                                         6,157                        6,863 
 
 
Stockholders' deficit: 
Common stock, par value $0.001; shares authorized 
 250,000,000 at December 31, 2014 and 150,000,000 
 at December 31, 2013; 83,665,402 shares issued and 
 outstanding at December 31, 2014 and at 
 December 31, 2013                                                                   84                           84 
Additional paid-in capital                                                      111,583                      111,302 
Accumulated deficit                                                          (113,014 )                   (111,674 ) 
Accumulated other comprehensive income / (loss)                                     812                        (146) 
 
        Total stockholders' deficit                                              (535)                         (434) 
 
        Total liabilities and stockholders' deficit                             $ 5,622                      $ 6,429 
 
 
 

PROPHOTONIX LIMITED

CONSOLIDATED STATEMENTS OF CASH FLOWS

In thousands

(unaudited)

 
 
                Years Ended December 31                               2014                            2013 
 
 Cash flows from operating activities 
 Net loss                                                                     $ (1,340)                      $ (1,153) 
 Adjustments to reconcile net loss to net cash used in 
 operating activities: 
        Stock-based compensation expense                                            280                            169 
        Depreciation and amortization                                               258                            332 
        Foreign exchange loss / (gain)                                            1,066                          (408) 
        Amortization of debt discount and financing 
         costs                                                                      186                             96 
        (Loss) / gain on disposal of assets                                           4                            (7) 
        Provision for inventories                                                    55                            120 
        Provision for bad debts                                                       5                           (12) 
 Other change in assets and liabilities: 
        Accounts receivable                                                       (395)                          (222) 
        Inventories                                                                  38                            (8) 
        Prepaid expenses and other current assets                                    23                             20 
        Accounts payable                                                            100                          (518) 
        Accrued expenses                                                          (248)                            171 
        Other assets and liabilities                                                (2)                            (9) 
 
 Net cash provided by (used in) operating activities                                 30                        (1,429) 
 
 
 Investing 
 Purchase of property, plant and equipment                                        (64 )                          (17 ) 
 
 Net cash used in investing activities                                            (64 )                          (17 ) 
 
 Financing 
 Borrowings of revolving credit facilities, net                                     144                            438 

1 Year Prophotonix S Chart

1 Year Prophotonix S Chart

1 Month Prophotonix S Chart

1 Month Prophotonix S Chart